Stockreport

PURE Bioscience GAAP EPS of $0.00, revenue of $707M [Seeking Alpha]

PURE BIOSCIENCE  (PURE) 
US:NASDAQ Investor Relations: purebio.com/investors
PDF Net loss for the fiscal first quarter ended October 31, 2025, was $464,000, compared to $689,000 for the fiscal first quarter ended October 31, 2024. Net loss, exclud [Read more]